Leukemic cells expressing NCOR1-LYN are sensitive to dasatinib in vivo in a patient-derived xenograft mouse model

Leukemia. 2021 Jul;35(7):2092-2096. doi: 10.1038/s41375-020-01091-3. Epub 2020 Nov 16.

¹ Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
² Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. imamura@koto.kpu-m.ac.jp.
³ Department of Pediatrics, Kyoto University, Kyoto, Japan.
⁴ Department of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan.
⁵ Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan.
⁶ Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
⁷ Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
⁸ Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan.
⁹ Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
¹⁰ Drug Discovery Technology Development Office, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

No abstract available

Publication types